Clovis Oncology Inc Here's the Reason Why Clovis Oncology (NASDAQ: CLVS) Surged on Friday Shares of Clovis Oncology, Inc. (NASDAQ: CLVS) rocketed 47.74% during the trading session of Friday after the firm disclosed that encouraging results from the Phase III trial for its ovarian cancer drug, Rubraca.
